Prostate cancer is the 2nd most common cancer in men and the 4th overall. In 2020 , more than 1.4 million new prostate cancer cases were reported. In recent years, the incidence of prostate cancer has reached its highest levels due to more precise and timely diagnoses and an increase in average lifespan. Therefore, prostate cancer must be promptly diagnosed and treated to avoid high morbidity and mortality. This activity reviews the role of nuclear medicine in evaluating and treating patients with this condition.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/145334
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.5 hours
Nursing: 1.5 hours
Pharmacy: 1.5 hours - MOC Credit Details: ABS - 1.5 Point; Credit Type(s): Accredited CME (ABS)
ABPATH - 1.5 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABIM - 1.5 Point; Credit Type(s): Medical Knowledge (ABIM)
ABS - 1.5 Point; Credit Type(s): Self-Assessment (ABS) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: All Practice Areas (e.g. ethics), General Surgery, Medical Oncology
Subscribe
Login
0 Comments
Oldest